Home

Biotech

Broadband

B2B Internet

Europe 2001

Internet

Internet 
Architecture

Internet 
Infrastructure

Market 2000+

Oil Services

Pharmaceutical

Regional Bank

Retail

Semiconductor

Software

Telecom

Utilities

Wireless
Exelixis Inc (NASDAQ GS:EXEL)9/3/2010
most recent headlinesmore headlines:       
FRIDAY, SEPTEMBER 03, 2010
8:00 PMExelixis Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - BusinessWire
FRIDAY, AUGUST 06, 2010
6:30 AMExelixis Announces August 12 Webcast of Presentation at the Canaccord Genuity 30th Annual Growth Conference - BusinessWire
THURSDAY, AUGUST 05, 2010
4:10 PMExelixis Announces Second Quarter 2010 Financial Results - BusinessWire
THURSDAY, JULY 29, 2010
6:00 AMExelixis Announces August 5 Webcast of Second Quarter 2010 Financial Results Conference Call - BusinessWire
WEDNESDAY, JUNE 30, 2010
4:14 PMExelixis Announces Appointment of New CEO - BusinessWire
4:01 PMBiogen Idec Names George Scangos Chief Executive Officer - BusinessWire
MONDAY, JUNE 21, 2010
3:22 AMReminder: Exelixis Announces June 21 Webcast of Conference Call Update on Development Collaboration with Bristol-Myers Squibb Company for XL184 - BusinessWire
1:15 AMExelixis Regains Full Rights to Develop and Commercialize XL184 - BusinessWire
FRIDAY, JUNE 18, 2010
10:10 PMExelixis Announces June 21 Webcast of Conference Call Update on Development Collaboration with Bristol-Myers Squibb Company for XL184 - BusinessWire
THURSDAY, JUNE 10, 2010
7:15 PMExelixis Announces June 15 Webcast of Presentation at the Goldman Sachs 31st Annual Global Healthcare Conference - BusinessWire


Quotes delayed at least 15 minutes. Market data provided by Interactive Data.
Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.

HOLDRS Defined |  HOLDRS Outstanding  |  FAQ  |  Proxies by email  |  Investment Strategies
Spin-Offs & Changes  |  Current Trading  |  Download a Prospectus  |  Site Map

Merrill Lynch, Pierce, Fenner & Smith Incorporated is a registered broker-dealer and a wholly-owned subsidiary of Bank of America Corporation.
Securities Products: Are Not FDIC Insured • Are Not Bank Guaranteed • May Lose Value.

The information in this Internet site is directed at, and is intended for distribution to, and for use by, persons in the U.S. only, and is not intended for distribution to or use by any person in any other jurisdiction. Merrill Lynch does not warrant the accuracy or completeness of any price, tax, cost basis, or other information on this site, or any investment, tax or other benefits associated with HOLDRS.

The information on HOLDRSSM contained in this Internet site is solely for informational purposes and does not constitute either an offer to sell or the solicitation of an offer to buy HOLDRS. This information on HOLDRS is not, and is not intended to be, a complete discussion of all material information you should know about HOLDRS. If you are considering whether to purchase a HOLDRS security, you should carefully read the relevant prospectus prior to making a purchase. You should not rely on the information contained in this Internet site. Please view Terms of Use and Legal Notices for additional important legal information and the terms and conditions governing your use of this site.

U.S. Patent Pending.
HOLDRS and HOLding Company Depositary ReceiptS are service marks of Merrill Lynch & Co., Inc.

© Copyright 2000, Merrill Lynch, Pierce, Fenner & Smith Incorporated. Member, Securities Investor Protection Corporation (SIPC). All rights reserved.